Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
Research Watch

YY1 Facilitates Enhancer–Promoter Contacts to Promote Gene Expression

DOI: 10.1158/2159-8290.CD-RW2017-233 Published February 2018
  • Article
  • Info & Metrics
  • PDF
Loading
  • Major finding: YY1 preferentially occupies active enhancers and promoters and forms dimers to promote DNA looping.

  • Concept: YY1 may act analogously to CTCF, which binds insulators to form TADs, to form enhancer–promoter loops.

  • Impact: YY1 enables enhancer–promoter contacts to control gene expression in malignant and nonmalignant cells.

Transcription factors bind to enhancers and promoters at sites of physical contact created by DNA looping to promote gene transcription, but the proteins that facilitate structural interactions between enhancers and promoters remain poorly understood. CTCF is one such DNA binding protein. CTCF–CTCF interactions are associated with the large DNA loops that create topologically associating domains (TAD) that insulate genes and enhancers within the CTCF–CTCF loop from elements outside the loop. In this manner, CTCF–CTCF loops constrain DNA interactions within the loop to facilitate enhancer–promoter interactions. However, CTCF is not present at the majority of enhancer–promoter interactions and is only occasionally directly involved in enhancer–promoter interactions. Weintraub, Li, and colleagues hypothesized that a bridging protein (similar to CTCF) might facilitate enhancer–promoter contacts and identified Yin Yang 1 (YY1), a zinc-finger transcription factor overexpressed in many cancers, as a candidate protein via chromatin immunoprecipitation with mass spectrometry (ChIP-MS). In embryonic stem cells, YY1 occupied active enhancers and promoters, whereas CTCF preferentially occupied insulator elements and dimerized to facilitate DNA looping. YY1 was also enriched at active enhancers and promoters in mammalian cell lines, including in colorectal cancer, hepatocellular carcinoma, T-cell acute lymphoblastic leukemia, and chronic myeloid leukemia cells. These findings suggested that YY1–YY1 interactions may induce enhancer–promoter loop formation. Indeed, YY1 enhanced the rate of DNA ligation in an in vitro circularization assay, indicating that YY1 may directly facilitate DNA interactions. Moreover, deletion of YY1 binding sites reduced the frequency of enhancer–promoter contacts, and depletion of the YY1 protein reduced expression of genes generally occupied by YY1. Collectively, these findings support a direct role for YY1 in facilitating enhancer–promoter interactions that facilitate gene expression in malignant and nonmalignant cells.

Weintraub AS, Li CH, Zamudio AV, Sigova AA, Hannett NM, Day DS, et al. YY1 is a structural regulator of enhancer-promoter loops. Cell 2017;171:1573–88.e28.

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.

  • ©2018 American Association for Cancer Research.
View Abstract
PreviousNext
Back to top
Cancer Discovery: 8 (2)
February 2018
Volume 8, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
YY1 Facilitates Enhancer–Promoter Contacts to Promote Gene Expression
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
YY1 Facilitates Enhancer–Promoter Contacts to Promote Gene Expression
Cancer Discov February 1 2018 (8) (2) 135; DOI: 10.1158/2159-8290.CD-RW2017-233

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
YY1 Facilitates Enhancer–Promoter Contacts to Promote Gene Expression
Cancer Discov February 1 2018 (8) (2) 135; DOI: 10.1158/2159-8290.CD-RW2017-233
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • The C-Terminal Domain of SMARCB1 Mediates Chromatin Remodeling
  • CD80 Dimerization with PD-L1 in Cis Disrupts CTLA4–CD80 Interactions
  • Peritumoral YAP and TAZ Expression Suppresses Tumor Growth in Mice
Show more Research Watch

Gene Expression

  • A Subset of Gene Promoters Exhibit Both Promoter and Enhancer Activity
  • p53 Regulates Noncoding RNA Transcription at Enhancers
Show more Gene Expression
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement